SciELO - Scientific Electronic Library Online

 
vol.50 número3Oncogenicidade do papilomavírus humano e o grau de neoplasia intra-epitelial anal em doentes HIV positivoAspectos da gravidez e pós-parto de adolescentes portadoras de febre reumática índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista da Associação Médica Brasileira

versão impressa ISSN 0104-4230versão On-line ISSN 1806-9282

Resumo

SANTOS, Flávia Leite Souza et al. Hematological features and expression profile of myeloid antigens of acute promyelocytic leukemia patients: analysis of prognostic factors for development of the retinoic acid syndrome. Rev. Assoc. Med. Bras. [online]. 2004, vol.50, n.3, pp.286-292. ISSN 1806-9282.  https://doi.org/10.1590/S0104-42302004000300036.

BACKGROUND: Acute Promyelocytic Leukemia (APL) is characterized by its good response to treatment with all trans retinoic acid (ATRA). However, some patients receiving ATRA develop a serious complication called retinoid syndrome (RS). The objective of this study was to compare the hematological and immunophenotypic features of APL patients who developed RS with those who did not. METHODS: We reviewed the medical records, roentgenograms, peripheral blood smears and bone marrow aspirates from 71 APL patients. Immunophenotypic analyses were available in 56 of these cases. Eight cases of RS were detected, whose clinical presentation was characterized by respiratory distress (n=8), impairment of the renal function (n=2), fever (n=5), weight gain (n=3), edema (n=3) and/or pleural effusion (n=5). The following variables were compared in patients with and without RS: hemoglobin levels, leukocyte and platelet counts, frequency of hypergranular and variant morphological subtypes, percentages of CD33+, CD13+, CD117+ blasts in the bone marrow, fluorescence intensity and variation of these markers in the leukemic cells, expressed as the median channel of fluorescence (MCF) and fluorescence coefficient of variation (CV), respectively. RESULTS: RS incidence was 11.26% and the average time for syndrome development was 11.5 days after starting ATRA treatment. All patients presented acute respiratory distress. Other symptoms included fever, weight gain, edema and renal insufficiency. The main radiological findings were ground glass opacities, increased vascular pedicle and peribronchial cuffing. There was no significant correlation between the variables selected and the risk of development of RS, however the Odds Ratios for patients presenting MCF for CD117 > 30 ua and CV for CD33 < 50 were of 7.14 (P=0.08) and 7.86 ( P=0.06), respectively. CONCLUSIONS: The incidence, as well as the clinical, radiological and laboratory features of RS in this group of Brazilian APL patients were similar to those described in literature. None of the variables studied were significantly correlated to a higher risk of developing RS.

Palavras-chave : Acute myeloid leukemia; Acute Promyelocytic leukemia; Retinoid syndrome; All trans retinoic acid; Immunophenotyping.

        · resumo em Português     · texto em Português     · Português ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons